About Golden Helix

Enabling precision medicine

Leadership

Andreas Scherer, Golden Helix President and CEO

Dr. Andreas Scherer

President & CEO

"Whether supporting national genomics initiatives, enabling enterprise-scale laboratories, or helping smaller labs access advanced capabilities, our mission remains unchanged: to deliver clinical genomics software that laboratories can rely on. Today and for the long term."

Under Dr. Scherer's leadership, Golden Helix has grown from a bioinformatics research tool provider into a global leader in clinical genomics software, trusted by diagnostic labs, hospitals, and genome centers worldwide.

Our Mission

Golden Helix develops industry-leading clinical genomics software that empowers healthcare professionals and researchers to analyze and interpret NGS data with confidence. From variant analysis to clinical reporting, our platform supports the full diagnostic workflow.

We've helped hundreds of institutions across the globe adopt precision medicine, delivering tools that are powerful enough for the most complex analyses yet intuitive enough for teams at every level.

1998

Founded

400+

Institutions Worldwide

60+

Countries

1M+

Samples Analyzed

What Drives Us

We stay committed to our core values across everything we build and every customer we serve.

Improving Human Health

Every feature we build is guided by its potential to improve patient outcomes and advance clinical genomics.

Innovation

We push the boundaries of what's possible in genomic analysis, from AI-powered classification to integrated clinical workflows.

Exceptional Support

Our scientists and engineers work directly with customers, providing responsive, expert-level technical support.

Global Reach

With customers on every continent and a distribution partner in Japan, we serve the worldwide clinical genomics community.